CGEN vs ALLO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CGEN

39.5
AI Score
VS
ALLO Wins

ALLO

46.4
AI Score

Investment Advisor Scores

CGEN

40score
Recommendation
SELL

ALLO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGEN ALLO Winner
Net Income 35.34M -190.89M CGEN
Operating Income 31.33M -209.31M CGEN
ROE 34.4% -65.3% CGEN
ROA 22.6% -45.9% CGEN
Total Assets 156.57M 415.90M ALLO
Cash 90.60M 51.69M CGEN
Current Ratio 6.56 7.93 ALLO
Free Cash Flow 31.33M -149.63M CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: +11.8% · 3M: +0.2% ALLO 1M: +14.8% · 3M: +6.6%

Current Technical Phase

CGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.62

ALLO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.7 · Price: $2.09

Fundamentals Snapshot

Metric CGEN ALLO
Market Cap
Forward P/E -7.1 -3.0
Trailing P/E 7.0
Revenue (TTM)
Revenue Growth 1.1% -1.0%
Gross Margin 0.9% -25.4%
Operating Margin -3.4% -10.1%
EPS 0.38 -0.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ALLO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.